BlackRock’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281M Buy
8,442,133
+232,741
+3% +$7.81M ﹤0.01% 1468
2025
Q4
$284M Buy
8,209,392
+82,166
+1% +$2.62M ﹤0.01% 1465
2025
Q3
$221M Sell
8,127,226
-715,409
-8% -$17.3M ﹤0.01% 1610
2025
Q2
$186M Sell
8,842,635
-313,882
-3% -$6.02M ﹤0.01% 1662
2025
Q1
$150M Buy
9,156,517
+779,461
+9% +$16.6M ﹤0.01% 1755
2024
Q4
$215M Buy
8,377,056
+696,115
+9% +$19.7M ﹤0.01% 1635
2024
Q3
$243M Buy
7,680,941
+873,151
+13% +$33.1M 0.01% 1538
2024
Q2
$239M Buy
6,807,790
+842,377
+14% +$33.4M 0.01% 1503
2024
Q1
$262M Buy
5,965,413
+528,745
+10% +$22.7M 0.01% 1465
2023
Q4
$193M Buy
5,436,668
+843,095
+18% +$25.2M 0.01% 1670
2023
Q3
$124M Buy
4,593,573
+237,877
+5% +$6.03M ﹤0.01% 1865
2023
Q2
$102M Buy
4,355,696
+806,603
+23% +$16.6M ﹤0.01% 2035
2023
Q1
$48.7M Buy
3,549,093
+12,363
+0.3% +$206K ﹤0.01% 2464
2022
Q4
$64.3M Buy
3,536,730
+861,174
+32% +$14.5M ﹤0.01% 2297
2022
Q3
$39.9M Buy
2,675,556
+53,268
+2% +$692K ﹤0.01% 2619
2022
Q2
$36.2M Buy
2,622,288
+132,011
+5% +$1.47M ﹤0.01% 2711
2022
Q1
$27.9M Sell
2,490,277
-239,442
-9% -$3.53M ﹤0.01% 2962
2021
Q4
$64.5M Sell
2,729,719
-281,947
-9% -$6.55M ﹤0.01% 2488
2021
Q3
$76.8M Buy
3,011,666
+409,243
+16% +$9.56M ﹤0.01% 2378
2021
Q2
$54.6M Buy
2,602,423
+1,195,493
+85% +$24.6M ﹤0.01% 2637
2021
Q1
$33.1M Buy
1,406,930
+192,860
+16% +$3.72M ﹤0.01% 2892
2020
Q4
$17M Buy
1,214,070
+319,057
+36% +$4.32M ﹤0.01% 3092
2020
Q3
$11.2M Buy
895,013
+165,745
+23% +$2.05M ﹤0.01% 3157
2020
Q2
$10.4M Buy
729,268
+691,050
+1,808% +$5.44M ﹤0.01% 3167
2020
Q1
$158K Buy
38,218
+26,774
+234% +$190K ﹤0.01% 4268
2019
Q4
$86K Sell
11,444
-4,173
-27% -$29.8K ﹤0.01% 4465
2019
Q3
$142K Buy
15,617
+7,354
+89% +$56.1K ﹤0.01% 4378
2019
Q2
$82K Buy
+8,263
New +$89.9K ﹤0.01% 4504

Other funds holding IDYA